Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2019-02-26, Stock:DHR, The news for the past five days is as follows:
2019-02-19: nan
2019-02-20: NEWS1: FLIR Systems, Inc. (FLIR) Ex-Dividend Date Scheduled for February 21, 2019.NEWS2: FLIR Systems, Inc. (FLIR) Ex-Dividend Date Scheduled for February 21, 2019.NEWS3: Cummins Inc. (CMI) Ex-Dividend Date Scheduled for February 21, 2019.NEWS4: Cummins Inc. (CMI) Ex-Dividend Date Scheduled for February 21, 2019.NEWS5: Fortive Corporation (FTV) Ex-Dividend Date Scheduled for February 21, 2019.NEWS6: Fortive Corporation (FTV) Ex-Dividend Date Scheduled for February 21, 2019.
2019-02-21: NEWS1: IHI, TMO, DHR, BDX: ETF Inflow Alert.NEWS2: IHI, TMO, DHR, BDX: ETF Inflow Alert.NEWS3: Snap-On Incorporated (SNA) Ex-Dividend Date Scheduled for February 22, 2019.NEWS4: Snap-On Incorporated (SNA) Ex-Dividend Date Scheduled for February 22, 2019.NEWS5: Northrop Grumman Corporation (NOC) Ex-Dividend Date Scheduled for February 22, 2019.NEWS6: Northrop Grumman Corporation (NOC) Ex-Dividend Date Scheduled for February 22, 2019.NEWS7: MKS Instruments, Inc. (MKSI) Ex-Dividend Date Scheduled for February 22, 2019.NEWS8: MKS Instruments, Inc. (MKSI) Ex-Dividend Date Scheduled for February 22, 2019.NEWS9: Energizer Holdings, Inc. (ENR) Ex-Dividend Date Scheduled for February 22, 2019.NEWS10: Energizer Holdings, Inc. (ENR) Ex-Dividend Date Scheduled for February 22, 2019.
2019-02-22: NEWS1: Nordson Corporation (NDSN) Ex-Dividend Date Scheduled for February 25, 2019.NEWS2: Nordson Corporation (NDSN) Ex-Dividend Date Scheduled for February 25, 2019.NEWS3: Brunswick Corporation (BC) Ex-Dividend Date Scheduled for February 25, 2019.NEWS4: Brunswick Corporation (BC) Ex-Dividend Date Scheduled for February 25, 2019.
2019-02-25: NEWS1: Mario Gabelli's take on today's flurry of M&A activity.NEWS2: Danaher Announces Offerings Of Common Stock And Mandatory Convertible Preferred Stock.NEWS3: Danaher Stock Surges on GE Biopharma Deal.NEWS4: Danaher Stock Surges on GE Biopharma Deal.NEWS5: Why Danaher, CRISPR Therapeutics, and Clementia Pharmaceuticals Jumped Today.NEWS6: GE Surges After Agreeing to $21.4 Billion Sale of BioPharma Unit.NEWS7: General Electric Shares Surge After Selling BioPharma Unit to Danaher.NEWS8: Pre-Markets Up, GE Sells Off Biopharma Biz.NEWS9: Danaher To Buy GE Biopharma For $21.4 Billion — But A Key IPO Is Now In Doubt.NEWS10: Dow Closes Modestly Higher After Trump Extends China Tariff Deadline.NEWS11: 5 Top Stock Trades for Tuesday: S&P 500, Amazon and Danaher.NEWS12: GE Puts Debt Cuts in Forefront With $21 Billion Asset Sale.NEWS13: GE inks $21 billion biopharma sale to Danaher in U-turn under Culp.NEWS14: Why General Electric Stock Popped 15% This Morning.NEWS15: Why General Electric Stock Popped 15% This Morning.NEWS16: Pre-Markets Up, GE Sells Off Biopharma Biz.NEWS17: GE debt rallies, bond insurance price drops on Danaher deal.NEWS18: Dow Rises Solidly After Trump Extends China Tariff Deadline.NEWS19: Stock Market News: Barrick Gold Gets Hostile, GE Soars.NEWS20: Stock Market News: Barrick Gold Gets Hostile, GE Soars.NEWS21: Buffett Missing in Action as GE’s Turnaround Plan Gets Upvote.NEWS22: GE Healthcare spinoff likely shelved for 2019.NEWS23: Danaher Stock Surges on GE Biopharma Deal.NEWS24: Why General Electric Stock Popped 15% This Morning.NEWS25: Positive Development on Trade War Front.NEWS26: Positive Development on Trade War Front.NEWS27: S&P 500 Movers: NEM, GE.NEWS28: S&P 500 Movers: NEM, GE.NEWS29: Year-Long GE Transportation-Wabtec Merger Completed.NEWS30: Danaher&apos;s credit rating could be cut more than 1 notch after GE biopharma deal--Moody&apos;s.NEWS31: Danaher's credit rating could be cut more than 1 notch after GE biopharma deal--Moody's.NEWS32: Stock Market News: Barrick Gold Gets Hostile, GE Soars.NEWS33: Danaher acquiring GE biopharma business for $21.4B.NEWS34: Danaher acquires GE biopharma business for $21.4B.NEWS35: GE chief Culp sells biopharma business for $21.4 billion.NEWS36: Danaher Luxembourg Finance S.A. -- Moody's places ratings of Danaher on review for downgrade following announcement of plan to acquire certain of GE's biologics businesses.NEWS37: Bodenholm Capital’s Returns, AUM and Holdings.NEWS38: Positive Development on Trade War Front.NEWS39: GE Soars on `Favorable&apos; Deal as Street Awaits Power Plan.NEWS40: Pre-Markets Up, GE Sells Off Biopharma Biz.NEWS41: Danaher to IPO dental unit after $21.4 billion deal to buy GE's biopharma business.NEWS42: GE CEO Larry Culp: Danaher deal is the superior path to a health-care IPO.NEWS43: Our Thesis Plays Out as GE Sells BioPharma to Danaher.NEWS44: Danaher to IPO dental unit after $21.4 bln deal to buy GE's biopharma business.NEWS45: GE Deal With Danaher Shows Culp Is All About the Balance Sheet.NEWS46: GE Stock Rises on Announcement of BioPharma Unit Sale to Danaher.NEWS47: GE chief Culp sells biopharma business for $21.4 billion.NEWS48: GE credit rating won&apos;t change after $21 billion deal to sell biopharma business--S&P Global.NEWS49: In $21B deal, GE to sell life sciences business to Culp’s old firm.NEWS50: GE sells biopharma unit for $21 billion.NEWS51: [$$] FirstFT: Today’s top stories.NEWS52: GE sells biopharma unit for $21 billion.NEWS53: GE&apos;s stock soars after deal to sell biopharma business to Danaher for $21.4 billion.NEWS54: GE shares surge 17% after Danaher agrees to buy biopharma business for $21.4 billion.NEWS55: Danaher to Acquire the Biopharma Business of General Electric Life Sciences for $21.4 Billion.NEWS56: General Electric Jumps 15% After Selling Biopharma Business.NEWS57: [$$] General Electric to sell slice of life sciences unit in $21bn deal.

Answer: Rise